LILLY ASIA VENTURES
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on opportunities in China, although they will consider investment opportunities elsewhere in east and south Asia.
LILLY ASIA VENTURES
Social Links:
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
2008-01-01
Status:
Active
Contact:
+86 21 2316 9588
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default ASP.NET IIS DigiCert SSL ASP.NET 4.0 IIS 8 Encryption Everywhere China Telecom
Similar Organizations
ARCH Venture Partners
ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Wisconsin Investment Partners
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-02 | Neukio Biotherapeutics | Lilly Asia Ventures investment in Series A - Neukio Biotherapeutics | 50 M USD |
| 2022-07-04 | ClinChoiceๆ็ฟ | Lilly Asia Ventures investment in Series E - ClinChoiceๆ็ฟ | 150 M USD |
| 2022-06-02 | ProfoundBio | Lilly Asia Ventures investment in Series A - ProfoundBio | 70 M USD |
| 2022-04-07 | Rona Therapeutics | Lilly Asia Ventures investment in Series A - Rona Therapeutics | 33 M USD |
| 2022-03-14 | IMPACT Therapeutics | Lilly Asia Ventures investment in Series D - IMPACT Therapeutics | N/A |
| 2022-02-28 | GluBio Therapeutics | Lilly Asia Ventures investment in Series A - GluBio Therapeutics | 50 M USD |
| 2022-02-15 | ArriVent Biopharma | Lilly Asia Ventures investment in Series A - ArriVent Biopharma | 69 M USD |
| 2022-02-08 | Pilot Biotechnology | Lilly Asia Ventures investment in Series C - Pilot Biotechnology | 100 M CNY |
| 2022-01-06 | Virtue Diagnostics | Lilly Asia Ventures investment in Series B - Virtue Diagnostics | 100 M USD |
| 2022-01-01 | ImmuneOnco Biopharma | Lilly Asia Ventures investment in Series C - ImmuneOnco Biopharma | 100 M USD |